Loading data
ABOSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 104.89 m USD | 93.8 m USD | 42.32 m USD | 32.36 m USD | 12.31 m USD |
| Operating profit | -123.83 m USD | -114.02 m USD | -61.14 m USD | -45.24 m USD | -19.58 m USD |
| Interest expense | — | — | 581 k USD | 0 USD | — |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -121.34 m USD | -102.33 m USD | -52.37 m USD | -42.86 m USD | -100.61 m USD |
| Basic earnings per share | -2 USD/share | -1.71 USD/share | -1.08 USD/share | -1.06 USD/share | -5.02 USD/share |
| Diluted earnings per share | -2 USD/share | -1.71 USD/share | -1.08 USD/share | -1.06 USD/share | -5.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.